Skip to main content
See every side of every news story
Published • loading... • Updated

We're raising our price target on Eli Lilly as the obesity-drug boom rolls on

Summary by CNBC
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNBC broke the news in Englewood Cliffs, United States on Thursday, October 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal